A N S Medical Limited 09818597 false 2022-11-01 2023-10-31 2023-10-31 The principal activity of the company is that of locum dental practice activities Digita Accounts Production Advanced 6.30.9574.0 true true 09818597 2022-11-01 2023-10-31 09818597 2023-10-31 09818597 core:RetainedEarningsAccumulatedLosses 2023-10-31 09818597 core:ShareCapital 2023-10-31 09818597 core:HirePurchaseContracts core:CurrentFinancialInstruments 2023-10-31 09818597 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2023-10-31 09818597 core:CurrentFinancialInstruments 2023-10-31 09818597 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 09818597 core:Non-currentFinancialInstruments core:AfterOneYear 2023-10-31 09818597 core:FurnitureFittingsToolsEquipment 2023-10-31 09818597 core:MotorVehicles 2023-10-31 09818597 core:OtherPropertyPlantEquipment 2023-10-31 09818597 bus:SmallEntities 2022-11-01 2023-10-31 09818597 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 09818597 bus:FullAccounts 2022-11-01 2023-10-31 09818597 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 09818597 bus:RegisteredOffice 2022-11-01 2023-10-31 09818597 bus:Director1 2022-11-01 2023-10-31 09818597 bus:Director2 2022-11-01 2023-10-31 09818597 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 09818597 core:FurnitureFittingsToolsEquipment 2022-11-01 2023-10-31 09818597 core:MotorVehicles 2022-11-01 2023-10-31 09818597 core:OfficeEquipment 2022-11-01 2023-10-31 09818597 core:OtherPropertyPlantEquipment 2022-11-01 2023-10-31 09818597 core:PlantMachinery 2022-11-01 2023-10-31 09818597 countries:AllCountries 2022-11-01 2023-10-31 09818597 2022-10-31 09818597 core:FurnitureFittingsToolsEquipment 2022-10-31 09818597 core:MotorVehicles 2022-10-31 09818597 core:OtherPropertyPlantEquipment 2022-10-31 09818597 2021-11-01 2022-10-31 09818597 2022-10-31 09818597 core:RetainedEarningsAccumulatedLosses 2022-10-31 09818597 core:ShareCapital 2022-10-31 09818597 core:HirePurchaseContracts core:CurrentFinancialInstruments 2022-10-31 09818597 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2022-10-31 09818597 core:CurrentFinancialInstruments 2022-10-31 09818597 core:CurrentFinancialInstruments core:WithinOneYear 2022-10-31 09818597 core:Non-currentFinancialInstruments core:AfterOneYear 2022-10-31 09818597 core:FurnitureFittingsToolsEquipment 2022-10-31 09818597 core:MotorVehicles 2022-10-31 09818597 core:OtherPropertyPlantEquipment 2022-10-31 iso4217:GBP xbrli:pure

Registration number: 09818597

A N S Medical Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 October 2023

 

A N S Medical Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

A N S Medical Limited

Company Information

Directors

Dr A Shrivastava

Dr N S Soomro

Registered office

84 Compton Avenue
Poole
BH14 8PY

 

A N S Medical Limited

(Registration number: 09818597)
Balance Sheet as at 31 October 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

61,671

3,039

Current assets

 

Debtors

5

32,683

40,277

Cash at bank and in hand

 

41,443

20,944

 

74,126

61,221

Creditors: Amounts falling due within one year

6

(65,968)

(62,991)

Net current assets/(liabilities)

 

8,158

(1,770)

Total assets less current liabilities

 

69,829

1,269

Creditors: Amounts falling due after more than one year

6

(50,160)

-

Provisions for liabilities

(13,876)

(1,124)

Net assets

 

5,793

145

Capital and reserves

 

Called up share capital

100

100

Retained earnings

5,693

45

Shareholders' funds

 

5,793

145

For the financial year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 24 January 2024 and signed on its behalf by:
 

.........................................
Dr N S Soomro
Director

 

A N S Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
84 Compton Avenue
Poole
BH14 8PY

The principal place of business is:
84 Compton Avenue
Poole
BH14 8PY

These financial statements were authorised for issue by the Board on 24 January 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

A N S Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% reducing balance

Plant and machinery

20% reducing balance

Motor vehicles

20% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

A N S Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

A N S Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2022 - 2).

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Plant and machinery
£

Total
£

Cost or valuation

At 1 November 2022

1,898

-

3,300

5,198

Additions

-

61,864

-

61,864

At 31 October 2023

1,898

61,864

3,300

67,062

Depreciation

At 1 November 2022

971

-

1,188

2,159

Charge for the year

232

2,578

422

3,232

At 31 October 2023

1,203

2,578

1,610

5,391

Carrying amount

At 31 October 2023

695

59,286

1,690

61,671

At 31 October 2022

927

-

2,112

3,039

5

Debtors

Current

Note

2023
£

2022
£

Trade debtors

 

25,674

-

Amounts owed by related parties

-

33,789

Prepayments

 

415

402

Other debtors

 

6,594

6,086

   

32,683

40,277

 

A N S Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

6

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Bank loans and overdrafts

7

7,461

-

Directors loan account

1,173

-

Other creditors

 

57,334

62,991

 

65,968

62,991

Due after one year

 

Loans and borrowings

7

50,160

-

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

7

50,160

-

7

Loans and borrowings

2023
£

2022
£

Non-current loans and borrowings

Hire purchase contracts

50,160

-

2023
£

2022
£

Current loans and borrowings

Hire purchase contracts

7,461

-